A Randomized Comparison of Radiation Therapy Techniques in the Management of Node Positive Breast Cancer
Sponsor: University of Michigan Rogel Cancer Center
This PHASE1/PHASE2 trial investigates Breast Cancer and is currently completed. University of Michigan Rogel Cancer Center leads this study, which shows 10 recorded versions since 2006 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE1_PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE1_PHASE2
▶ Show 5 earlier versions
-
Feb 2019 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Feb 2019 [monthly]
Completed PHASE1_PHASE2
-
Nov 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
Feb 2017 — Nov 2017 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE1_PHASE2
First recorded
Apr 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Michigan Rogel Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .